Liver Lesion (Hepatic Lesion)

What is a Liver Lesion?

A liver lesion (or hepatic lesion) is any abnormal area in the liver detected on imaging studies. Lesions can be solid, cystic (fluid-filled), or mixed, and may be benign or malignant.

Imaging Appearance

On CT scan, liver lesions are characterized by:

Enhancement Pattern (Key to Diagnosis):

• Pre-contrast - Baseline density
• Arterial phase (25-30 sec after contrast)
• Portal venous phase (60-70 sec)
• Delayed phase (3-5 minutes)

Different lesion types show characteristic enhancement patterns that help identify them.

Common Types of Liver Lesions

Benign Lesions (Most Common)

1. Hemangioma (Most Common - 70%)

Imaging Features:

• Peripheral nodular enhancement in arterial phase
• Progressive central fill-in on delayed images
• Bright on T2-weighted MRI (light bulb sign)

Characteristics:

• Benign blood vessel tumor
• More common in women
• Usually ＜ 3 cm
• No treatment needed

2. Simple Hepatic Cyst

Imaging Features:

• Fluid density (near water - 0-20 HU)
• No enhancement with contrast
• Round, well-defined

Characteristics:

• Very common (5-10% of population)
• No symptoms unless very large
• No malignant potential

3. Focal Nodular Hyperplasia (FNH)

Imaging Features:

• Homogeneous arterial enhancement
• Central scar (may be visible)
• Rapid washout to isodense

Characteristics:

• Second most common benign lesion
• More common in women (20-50 years)
• Associated with oral contraceptives
• No treatment needed

4. Hepatic Adenoma

Imaging Features:

• Marked arterial enhancement
• May contain fat or hemorrhage
• Risk of bleeding

Characteristics:

• Rare, associated with oral contraceptives
• Risk of rupture if ＞ 5 cm
• Small risk of malignant transformation
• May require surgery

Malignant Lesions

1. Hepatocellular Carcinoma (HCC)

Imaging Features:

• Arterial hyperenhancement
• Washout on portal venous/delayed phases
• Capsule appearance

Risk Factors:

• Cirrhosis (70-90% of cases)
• Hepatitis B or C
• Fatty liver disease
• Alcohol abuse

Treatment:

• Surgery, ablation, transplant, or chemotherapy

2. Metastases (Most Common Malignant Liver Tumor)

Imaging Features:

• Multiple lesions typically
• Hypoenhancing (darker) on portal venous phase
• Rim enhancement possible

Primary Cancers That Metastasize to Liver:

• Colon (most common)
• Lung
• Breast
• Pancreas
• Stomach
• Melanoma

Treatment:

• Depends on primary cancer and extent

3. Cholangiocarcinoma (Bile Duct Cancer)

Imaging Features:

• Peripheral enhancement
• Delayed central enhancement
• Bile duct dilation

Characteristics:

• Rare but aggressive
• Risk factors: PSC, liver flukes (Asia)

Risk Stratification

Low Risk (Likely Benign):

• Simple cyst appearance
• Classic hemangioma features
• Small (＜ 1 cm) in healthy liver

Intermediate Risk:

• Atypical features
• Indeterminate enhancement
• May need additional imaging (MRI)

High Risk (Concern for Malignancy):

• Cirrhosis patient
• History of cancer
• Suspicious enhancement pattern
• Elevated AFP (alpha-fetoprotein)

Diagnosis

1. Imaging Studies

Contrast-Enhanced CT:

• Multi-phase imaging (arterial, portal, delayed)
• Excellent for characterization

MRI with Contrast:

• Gold standard for characterization
• Best for distinguishing benign from malignant
• Multiple sequences provide detailed information

Ultrasound:

• First-line screening
• Good for cysts and hemangiomas
• Limited for detailed characterization

PET-CT:

• For metastases evaluation
• Helps determine primary cancer source

2. Blood Tests

Liver Function Tests:

• ALT, AST - Liver inflammation
• ALP, Bilirubin - Bile duct function

Tumor Markers:

• AFP (Alpha-fetoprotein) - Elevated in HCC
• CEA, CA 19-9 - Elevated in metastases or cholangiocarcinoma

3. Biopsy (Select Cases Only)

Indications:

• Diagnosis uncertain after imaging
• No prior cancer history
• Will change management

Avoided When:

• Classic benign features (hemangioma, cyst)
• High surgical risk
• Risk of tumor seeding

Treatment

Benign Lesions

Hemangioma:

• No treatment needed
• Follow-up imaging only if symptomatic or uncertain

Simple Cyst:

• Observation
• Drainage only if causing symptoms

FNH:

• Observation
• No cancer risk
• May stop oral contraceptives if possible

Adenoma:

• Surgery if ＞ 5 cm (bleeding risk)
• Stop oral contraceptives
• Serial imaging for smaller lesions

Malignant Lesions

HCC:

• Surgical resection (if solitary, good liver function)
• Liver transplant (if cirrhosis, meets Milan criteria)
• Ablation (RFA, microwave) for small tumors
• TACE (chemoembolization) for larger tumors
• Systemic therapy (sorafenib, lenvatinib) for advanced disease

Metastases:

• Resection (if limited disease, resectable)
• Chemotherapy (standard for most)
• Ablation (for oligometastatic disease)
• Palliative care for extensive disease

Follow-Up

Benign Lesions:

• Classic benign (hemangioma ＜ 3 cm): No follow-up needed
• Indeterminate small lesions: Repeat imaging in 3-6 months
• Adenoma: Annual imaging

High-Risk Patients (Cirrhosis):

• HCC surveillance: Ultrasound + AFP every 6 months
• MRI or CT if concerning findings

Prognosis

Benign Lesions:

• Excellent prognosis
• No impact on life expectancy
• Rarely cause symptoms

Malignant Lesions:

• HCC (early-stage): 5-year survival 50-70% with treatment
• HCC (advanced): 5-year survival ＜ 10%
• Metastases: Depends on primary cancer; median survival 6-24 months

What Should You Do?

If a liver lesion is found:

1. Don't Panic:

• Most are benign
• Proper characterization is key

2. Get Proper Imaging:

• Multi-phase CT or MRI with contrast
• Ensure radiologist has clinical history

3. Review Risk Factors:

• Cirrhosis, hepatitis, cancer history
• Medication use (oral contraceptives)

4. Follow Recommendations:

• If benign and classic features → reassurance
• If indeterminate → additional imaging or short-interval follow-up
• If malignant → oncology referral

5. For Benign Lesions:

• No lifestyle changes needed
• No dietary restrictions
• Routine health maintenance

Prevention

For Malignant Liver Disease:

• Hepatitis B vaccination
• Treat hepatitis C (curative now)
• Limit alcohol consumption
• Maintain healthy weight (prevent NAFLD)
• Cancer screening for early detection

Related Imaging Terms

• Hemangioma - Benign vascular tumor
• Focal nodular hyperplasia (FNH) - Benign proliferation
• Hepatocellular carcinoma (HCC) - Primary liver cancer

Common Questions

Can liver lesions go away?

Simple cysts and hemangiomas persist. Inflammatory lesions (abscesses) may resolve with treatment.

Do I need a biopsy?

Usually not. Most lesions can be characterized by imaging alone. Biopsy is reserved for uncertain cases.

Should I stop drinking alcohol?

If you have a benign lesion with healthy liver, moderate alcohol is generally okay. If you have cirrhosis or HCC risk, abstinence is recommended.

How often do I need follow-up imaging?

Depends on lesion type and risk factors. Classic benign lesions often need no follow-up.

---

Medical Disclaimer: This information is educational. Consult a hepatologist or oncologist for evaluation and management of liver lesions.